ViaNautis
Signal active
Organization
Contact Information
Overview
ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers such as the blood-brain barrier (BBB). PolyNaut, a versatile nano-engineered polymer technology that facilitates intracellular delivery, is used in collaboration with a number of partners. SomaServe is breaking new ground in the development of medications that can bypass various biological barriers and provide significant therapeutic benefits thanks to this technology.
About
Industries
Biotechnology, Medical, Biopharma
Founded
2018
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
ViaNautis headquartered in Europe, operates in the Biotechnology, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $989.5M in funding across 36 round(s). With a team of 11-50 employees, ViaNautis is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - ViaNautis, raised $24.6M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
8
Lead Investors
0
Total Funding Amount
$27.5M
Details
3
ViaNautis has raised a total of $27.5M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Seed | |||
| 2021 | Early Stage Venture | 2.9M | ||
| 2023 | Early Stage Venture | 24.6M |
Investors
ViaNautis is funded by 23 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| BGF Ventures | - | FUNDING ROUND - BGF Ventures | 24.6M |
| Origin Capital | - | FUNDING ROUND - Origin Capital | 24.6M |
| ViaNautis | - | FUNDING ROUND - ViaNautis | 24.6M |
| Eli Lilly | - | FUNDING ROUND - Eli Lilly | 24.6M |
Recent Activity
There is no recent news or activity for this profile.